Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

February Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured in the media and academic journals this month. This list includes Nelson Chao, MD; Pamela Bowman,BSN, RN, OCN; Tian Zhang, MD; Cristina Gasparetto, MD; and many others.

Barrett Appointed To Serve As ACCC Trustee

Nadine J. Barrett, PhD, inaugural director of Duke Cancer Institute’s Office of Health Equity and Disparities (OHED), has been appointed to serve as a trustee on the Association of Community Cancer Centers’ Board of Trustees. “The ACCC’s leadership and staff appreciate the work that you have done...

McCall Contributes to ISBER Best Practices

Shannon McCall, MD, co-founder and director of the BioRepository And Precision Pathology Center (BRPC) shared resource at Duke Cancer Institute, has contributed to the 4th edition of the International Society for Biological and Environmental Repositories’ (ISBER) Best Practices. Published on...

Sample Named Assistant Vice President, Clinical Programs

Laura Sample, MHA, has been named assistant vice president for Duke Cancer Institute’s clinical programs. In her new role, she will serve as the senior leader for the administrative functions of the disease-based programs, providing oversight for the development of strategic business plans focused...

Oncology Nurses Serve Up Meals Warming Body And Soul

Whether on the job, at home or beyond, compassion seems to be an essential characteristic that comes naturally for most nurses. Nowhere is this illustrated better than through the team of nurses manning Clinic 3-2 at Duke Cancer Center. When thoracic oncology medical assistant Suzanne Matkins, CMA...

Cancer Survivor Credits Care Team for Second and Third Chance at Life 

In the ‘70s, ‘80s and ‘90s, mother and homemaker Charlotte Miller was always on the move. Married to a textile manager, the couple married right out of high school in their home state of Pennsylvania. They relocated several times for his career — to North Carolina, then Ohio, Wisconsin,...

Pancreatic Cancer: Facing a Formidable Foe

In February 2016, Tara Wilkes left her job as a decorator and furniture sales associate, locked the door of her second home on Lake Waccamaw and moved back inland to the family home in Rockingham, North Carolina. “I just couldn’t do my job,” said Wilkes, a petite and active 56-year-old grandmother...

In Canines, A Novel Approach To An Old Drug

Cancer is the leading cause of death in dogs, with one in four developing the disease in his or her lifetime. For humans, it’s one in three. America’s 83 million pet dogs share our environment, have similar genomes and develop spontaneous tumors much like we do. Canine tumors have similar imaging...

Stinchcombe Named Associate Editor At JCO

Duke Cancer Institute thoracic oncologist Thomas Stinchcombe, MD , has been named associate editor for thoracic malignancies at the Journal of Clinical Oncology (JCO), starting in early March. Stinchcombe is a professor of medicine and an accomplished clinical investigator in the field of lung...

IBC Consortium To Host First-Ever Annual Meeting (2.28.18)

In partnership with the Duke School of Medicine, Duke Cancer Institute, Duke Department of Surgery, and the IBC Network Foundation , the Duke Consortium for Inflammatory Breast Cancer (IBC) will host its first-ever Annual Meeting, “Engaging Our Community in IBC Research and Awareness,” on Wednesday...

Researchers Identify New Way to Unmask Melanoma Cells to the Immune System

Melanomas have an especially lethal ability to turn off the body’s immune system, which enables these deadly skin cancers to grow and spread. And while new therapies have been effective in releasing the immune system’s restraints to unleash the body’s own cancer-fighting powers, they only work in...

Kirsch Leads First Trial of Immune Checkpoint Inhibitors For Non-Metastatic Sarcoma

A multi-institutional team of researchers led by Duke Cancer Institute (DCI) radiation oncologist David Kirsch, MD, PhD, has been awarded an eight-year, $2.5 million grant from Stand Up to Cancer . The funds support a clinical trial to investigate the efficacy of treatment of patients with high-...

Pages